0
0
10/2/22 at 4:00pm
Organization
Mims.com
Author
Natalia Reoutova
47 words
0
Comments
A real-world study of over 250,000 type 2 diabetes (T2D) patients from Hong Kong has found that use of renin-angiotensin-system inhibitors (RASIs) is ...
You are the first to view
https://specialty.mims.com/topic/use-of-ras-inhibitors-associated-with-lower-cancer-risk-in-t2d
Create an account
or login to join the discussion